UNSPSC 51162331: Aspirin/caffeine/chlorpheniramine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162331 Aspirin/caffeine/chlorpheniramine (Commodity) covers pharmaceutical products and related healthcare supplies purchased by state and local health agencies, correctional systems, and public health departments. Recent solicitations under this code show state and local governments buying parenteral nutrition solutions, intravenous products, controlled substances for incarcerated populations, and opioid-antagonist pharmaceuticals such as naloxone. The issuing bodies include state departments of corrections, county health departments, and county public health systems. Work involves product supply, delivery logistics with strict timeframe requirements (same-day or 24-hour turnaround for medical products), and in some cases clinical support such as lab monitoring and nutritional preparation. Bidders must hold state business licensures, pass background clearances, maintain commercial and professional liability insurance, and demonstrate documented experience with pharmaceutical preparation and delivery.

The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, soliciting parenteral products and services for eight correctional facilities across the state, with responses due October 7, 2026. The department anticipates awarding multiple contractors (up to three per region) for a contract term running November 26, 2026 through June 30, 2030, with pricing fixed for the initial two-year period. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, though that bid cycle closed in July 2023. The code shows recent activity in Washington and Florida; both opportunities reflect the growing state and local focus on pharmaceutical access for emergency response and correctional healthcare. The Washington procurement emphasizes state and local small-business, minority-owned, and women-owned business participation with specific utilization targets (25% small business, 10% MBE, 6% WBE, 5% VBE).